Endotoxin test by recombinant Factor C for 0.9% sodium chloride injection Teste de endotoxina por Fator C recombinante para solução injetável de cloreto

Molim Ghisleni,W. Quintilio,Jesus Andreoli Pinto,T. de,Adriana Bugno,Daniela Dal,Adriana Aparecida Buzzo Almódovar,E. Hilinski,Carla Lilian de Agostini Utescher
Abstract:Endotoxin contamination is a threat to the safety of pharmaceutical products, especially parenteral drugs. Any sterile and/or pyrogen-free pharmaceutical product requires regulatory specifications to ensure safe patient use. This study covers the performance evaluation study of an endotoxin quantitation commercial kit by recombinant Factor C (rFC), Endozyme II ® Go, for 0.9% sodium chloride injection. The samples were spiked with endotoxin solutions between 0.0005 and 10 EU/mL and tested by the rFC kit to evaluate precision, accuracy, detection and quantification limits, linearity, and robustness. Each of the six points was assayed at least five times. The relative standard deviation for precision testing ranged from 1.9 to 8.3%. The recovery accuracy values of endotoxin were between 61% and 125% for the range from 0.005 to 10 EU/mL. The results demonstrated that the rFC method allows endotoxin quantification with accuracy, precision, specificity, and linearity for the range of 0.005 and 10 EU/mL for 0.9% sodium chloride injection.
Medicine
What problem does this paper attempt to address?